Toronto's 1.5-million-sq-ft innovation hub has worked to commercialise publicly funded research since 2000; MaRS reports ventures it supported raised $19B in capital and added 33,000+ jobs (2010-2021), though MaRS's own finances have come under independent scrutiny.
19 $ billion
Capital raised by supported ventures (2010-2021)
11.5 $ billion
Cumulative revenue generated by supported ventures (2010-2021)
29.6 $ billion
GDP contribution attributed to supported ventures (2010-2021)
33000 jobs (more than)
Jobs created by supported ventures (2010-2021)
40 % decline
MaRS own revenue decline (2019-2023)
Details
Maturity
Established
Promoter
MaRS Discovery District (Province of Ontario, Government of Canada, University of Toronto and founding civic/academic leaders)
Period
2000-present
Keywords
Research commercialisation, technology transfer, health tech, cleantech
Context
MaRS Discovery District opened in Toronto in 2000 (its MaRS Centre building opened in 2005), founded by physician-researcher John Evans together with a group of civic, academic and business leaders, and modelled in part on Boston's Kendall Square biotech cluster. It occupies roughly 1.5 million square feet on Toronto's 'hospital row,' with a 2014 West Tower expansion and a 2023 waterfront building, and is funded mainly by the Province of Ontario and the Government of Canada alongside philanthropic and private capital.
Activities
MaRS Innovation, launched in 2008, pools intellectual-property rights from a consortium of 15 member institutions — including the University of Toronto, York University and several teaching hospitals — to provide centralised deal-structuring for commercialising publicly funded research. The Investment Accelerator Fund has invested roughly $80 million across more than 170 Ontario technology companies, and advisory services support over 1,200 startups. A 2024 pilot alongside University Health Network, Hospital for Sick Children and Sunnybrook Research Institute aims to speed medical-innovation commercialisation.
Results
MaRS' own impact reporting states that ventures it supported between 2010 and 2021 raised over $19 billion in capital, generated $11.5 billion in cumulative revenue, contributed $29.6 billion to Canada's GDP and created more than 33,000 jobs, with revenue growing at a 20.7% annualised rate. These figures are self-reported and have not been independently audited in the sources reviewed.
Conclusions
Independent reporting complicates the picture: The Globe and Mail reported that MaRS' own revenues fell 40% between 2019 and fiscal 2023 (down to $29.6 million), that the organisation posted losses in all five years reviewed, and that roughly two-thirds of its budget still depends on provincial and federal grants whose renewal is not guaranteed — prompting open debate about whether MaRS functions primarily as a real-estate operation or a genuine innovation engine.
Implementation
Indicative cost
Very high (> €5M) — 1.5 million sq ft campus across three phases (2005, 2014, 2023); ~$80 million Investment Accelerator Fund deployed across 170+ companies; MaRS' own annual revenue reported at $29.6 million (fiscal 2023, down 40% from 2019).
Time to results
Long (> 3 years) — Opened 2000 (MaRS Centre building 2005); West Tower expansion 2014; waterfront building 2023; MaRS Innovation IP-pooling launched 2008; impact figures reported for supported ventures 2010-2021.
Staffing & skills
Founded by physician-researcher John Evans with a group of civic, academic and business leaders, MaRS Innovation IP-pooling consortium spans 15 member institutions including the University of Toronto, York University and teaching hospitals
Conditions for success
Public funding backbone from the Province of Ontario and Government of Canada, supplemented by philanthropic and private capital
Centralised IP deal-structuring across a multi-institution consortium (MaRS Innovation) to avoid single-institution bottlenecks
Dedicated Investment Accelerator Fund (~$80m across 170+ companies) to bridge lab-to-market financing gaps
Common failure modes
The Globe and Mail reports a 40% revenue decline (2019-2023), losses in all five years reviewed, and roughly two-thirds budget dependency on government grants whose renewal is not guaranteed — a documented sustainability risk for the intermediary organisation itself, distinct from the ventures it supports
Knowledge Transfer Ireland publishes standardised annual metrics on how Irish universities license research to industry. Its 2024 survey recorded 221 …